Key result
Surgical patients with recent drug-eluting stent placement remain at risk for perioperative myocardial infarction secondary to stent thrombosis despite adherence to recommended antiplatelet regimens.
Patients with recent drug-eluting stent placement remain at high risk for perioperative myocardial infarction due to stent thrombosis during noncardiac surgery, requiring careful multidisciplinary management.
This article discusses how perioperative physicians are currently faced with unique challenges when providing care for surgical patients who have undergone recent percutaneous transluminal coronary angioplasty with drug-eluting stent (DES) placement. Despite adhering to the currently recommended antiplatelet regimens, these patients may still be at risk for sustaining a myocardial infarction secondary to stent thrombosis during the perioperative period. Given the high morbidity and mortality rates associated with perioperative myocardial infarction, it is important that the perioperative care of surgical patients with previous DES placement should be discussed, evaluated, and clarified by all practitioners who may be involved in their care.
No takes yet. Share an insight, caveat, or question.
Heir et al. (2009) conducted a review in Surgical patients with recent percutaneous transluminal coronary angioplasty with drug-eluting stent (DES) placement. Surgical patients with recent drug-eluting stent placement remain at risk for perioperative myocardial infarction secondary to stent thrombosis despite adherence to recommended antiplatelet regimens.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: